1CP
MDT icon

1015 Capital Partners’s Medtronic MDT Stock Holding History

1015 Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64K Sell
21
-1,468
-99% -$118K ﹤0.01% 365
2026
Q1 		$129K Hold
1,489
– – 0.13% 113
2025
Q4 		$143K Buy
+1,489
New +$145K 0.14% 104

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

1015 Capital Partners's MDT Position: Q2 2026 in Review

1015 Capital Partners reduced its Medtronic (MDT) stake by 99% in Q2 2026, selling an estimated $118K and leaving 21 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #365.

1015 Capital Partners first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $143K in Q4 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • 1015 Capital Partners held 21 shares of Medtronic worth $1.64K as of Q2 2026.
  • 1015 Capital Partners sold 1,468 Medtronic shares in Q2 2026, an estimated $118K.
  • Medtronic made up ﹤0.01% of 1015 Capital Partners's portfolio in Q2 2026, its #365 holding.
  • 1015 Capital Partners first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • 1015 Capital Partners's Medtronic position peaked at $143K in Q4 2025.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.